Category Archives: Life Sciences Industry News
Milken Institute Ranks Utah Sixth in Nation for Innovation Capacity
The Milken Institute 2020 State Technology and Science Index ranks Utah #6 in the nation for its knowledge economy and capacity for innovation – same ranking as last year. The index, published annually, compares each state’s capacity for achieving prosperity through scientific discovery and technological innovation, by analyzing their performance on a number of key […]
Quansys Biosciences Receives EUA for COVID-19 Antibody Test, Provides Exceptional Clinical Performance
Quansys Biosciences has received emergency use authorization (EUA) from the FDA for its COVID-19 antibody test. The test allows simultaneous detection of human antibodies to the SARS-CoV-2 S1 protein and the SARS-CoV-2 S2 protein, which has shown measurable improvement in clinical performance, compared to tests using a single protein. “This is very welcome news, said […]
SDP Oncology Announces First Patient Dosed in a Phase 1 Solid Tumor Study
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the PKM2 activator, TP-1454, in a Phase 1/1b study in patients with advanced metastatic or progressive solid tumors. “Dosing the first patient in this study marks an important milestone, as TP-1454 is the first PKM2 activator to be […]
BioHive Launched at Utah Life Sciences Summit – Join the Campaign
The 11th annual Utah Life Sciences Summit (ULSS) Nov. 9-11, went virtual this year. But despite the physical distance, the ULSS made news and ignited our life sciences industry with a special announcement — the launch of BioHive, a new bold campaign to brand and expand Utah’s life sciences ecosystem. ICYMI…view the video and see […]
Transit Scientifc’s New Angioplasty System Dilates Calcified & Fibrotic Vessels
Transit Scientific’s new FDA cleared XO Score system was successfully used to dilate multiple challenging fibrotic and calcific lesions in hemodialysis patients with stenotic and occluded fistulas. Dr. Richard Saxon, FSIR and member of the SDI Medical Group, while working at Tri City Medical Center Medical Center, Oceanside, California, USA performed the first procedures using […]
BioUtah Launches BioHive Initiative to Promote Utah’s Life Sciences Industry
Article courtesy of BusinessWire Local leaders to create ecosystem for innovation, job creation, and growth SALT LAKE CITY–(BUSINESS WIRE)–Since 2012, Utah’s life sciences community has grown faster than any other in the country. Through collective efforts of the more than 1,100 life sciences-related companies (and growing), it intends to continue that trend and join the […]
Dr. Dinesh C. Patel Honored with Utah Governor’s Lifetime Achievement Medal
Utah’s own life sciences entrepreneur, Dinesh C. Patel, PhD, has been honored with the Utah Governor’s Lifetime Achievement Medal for Science and Technology for his contribution in the field of biotechnology and pharmaceuticals. “This honor is well-deserved,” said Kelvyn Cullimore, president and CEO of BioUtah. “Dr. Patel has been instrumental in founding and bringing a […]
Sanofi Commits $1M to Support Parkinson’s Disease Genetic Research
Sanofi and the Parkinson’s Foundation announced on Wednesday a new research collaboration to advance the availability of genetic testing and counseling for people with Parkinson’s disease in the U.S. Over the next two years, Sanofi will provide $1 million in research funding to support the PD GENEration Mapping the Future of Parkinson’s Disease initiative. The […]
IDbyDNA and Illumina Launch New Rapid Test to Better Detect COVID-19, Flu, Respiratory Co-Infections
Utah-based IDbyDNA announced yesterday that, in an effort to help labs better identify respiratory pathogens and avoid overuse of antimicrobial drugs, IDbyDNA and Illumina, Inc. are co-launching the new Respiratory Pathogen ID/AMR Target Enrichment Assay. The test, currently for research use only, will improve testing for infectious diseases, including COVID-19, and will leverage IDbyDNA’s Explify® […]
SDP Oncology Announces First Patient Dosed in a Phase 1 Solid Tumor Study
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the PKM2 activator, TP-1454, in a Phase 1/1b study in patients with advanced metastatic or progressive solid tumors. “Dosing the first patient in this study marks an important milestone, as TP-1454 is the first PKM2 activator to be […]
Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed with TP-1454 in Patients with Advanced Solid Tumors
CAMBRIDGE, Mass., October 9, 2020 – Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today announced that the first patient has been dosed with TP-1454, an investigational small-molecule pyruvate kinase M2 isoform (PKM2) activator, administered alone and in combination with ipilimumab and nivolumab, in a Phase 1/1b study in patients with advanced […]
Mountain Pacific Venture Fund Invests in SLC Laparoscopic Device Company Xenocor
Utah-based Mountain Pacific Venture Fund (MPVF) announced on Monday an investment in Xenocor, a Salt Lake City-based medical device company that has developed the XenoscopeTM, a single-use, multi-purpose HD laparoscope with an integrated light source. Designed to be fog proof, the Xenoscope minimizes common visualization challenges and provides consistent image quality through electrocautery smoke. MPVF’s […]
